VEGF-Trap Modulates Retinal Inflammation in the Murine Oxygen-Induced Retinopathy (OIR) Model

Anti-Vascular Endothelial Growth Factor (VEGF) agents are the first-line treatment for retinal neovascular diseases, which represent the most prevalent causes of acquired vision loss world-wide. VEGF-Trap (Aflibercept, AFL), a recombinant decoy receptor recognizing ligands of both VEGFR-1 and -2, wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojo Arias, Jesús Eduardo, Englmaier, Vanessa Elisabeth, Jászai, József
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869660/
https://www.ncbi.nlm.nih.gov/pubmed/35203414
http://dx.doi.org/10.3390/biomedicines10020201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869660/
https://www.ncbi.nlm.nih.gov/pubmed/35203414
http://dx.doi.org/10.3390/biomedicines10020201

Ejemplares similares